Copyright Reports & Markets. All rights reserved.

Global Nanoparticles in Biotechnology and Pharmaceuticals Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Nanoparticles in Biotechnology and Pharmaceuticals Market Overview

      • 1.1 Product Overview and Scope of Nanoparticles in Biotechnology and Pharmaceuticals
      • 1.2 Nanoparticles in Biotechnology and Pharmaceuticals Segment by Type
        • 1.2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Fullerenes
        • 1.2.3 Liquid Crystals
        • 1.2.4 Liposomes
        • 1.2.5 Nanoshells
        • 1.2.6 Quantum dots
        • 1.2.7 Superparamagnetic nanoparticles
      • 1.3 Nanoparticles in Biotechnology and Pharmaceuticals Segment by Application
        • 1.3.1 Nanoparticles in Biotechnology and Pharmaceuticals Consumption Comparison by Application (2014-2025)
        • 1.3.2 Biotechnology
        • 1.3.3 Pharmaceutical
      • 1.4 Global Nanoparticles in Biotechnology and Pharmaceuticals Market by Region
        • 1.4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size
        • 1.5.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (2014-2025)
        • 1.5.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Production (2014-2025)

      2 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Competition by Manufacturers

      • 2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Nanoparticles in Biotechnology and Pharmaceuticals Production Sites, Area Served, Product Types
      • 2.5 Nanoparticles in Biotechnology and Pharmaceuticals Market Competitive Situation and Trends
        • 2.5.1 Nanoparticles in Biotechnology and Pharmaceuticals Market Concentration Rate
        • 2.5.2 Nanoparticles in Biotechnology and Pharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Market Share by Regions

      • 3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Market Share by Regions
      • 3.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Nanoparticles in Biotechnology and Pharmaceuticals Production
        • 3.4.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Production Growth Rate (2014-2019)
        • 3.4.2 North America Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Nanoparticles in Biotechnology and Pharmaceuticals Production
        • 3.5.1 Europe Nanoparticles in Biotechnology and Pharmaceuticals Production Growth Rate (2014-2019)
        • 3.5.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Nanoparticles in Biotechnology and Pharmaceuticals Production (2014-2019)
        • 3.6.1 China Nanoparticles in Biotechnology and Pharmaceuticals Production Growth Rate (2014-2019)
        • 3.6.2 China Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Nanoparticles in Biotechnology and Pharmaceuticals Production (2014-2019)
        • 3.7.1 Japan Nanoparticles in Biotechnology and Pharmaceuticals Production Growth Rate (2014-2019)
        • 3.7.2 Japan Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Regions

      • 4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Regions
      • 4.2 North America Nanoparticles in Biotechnology and Pharmaceuticals Consumption (2014-2019)
      • 4.3 Europe Nanoparticles in Biotechnology and Pharmaceuticals Consumption (2014-2019)
      • 4.4 China Nanoparticles in Biotechnology and Pharmaceuticals Consumption (2014-2019)
      • 4.5 Japan Nanoparticles in Biotechnology and Pharmaceuticals Consumption (2014-2019)

      5 Global Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price Trend by Type

      • 5.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Market Share by Type (2014-2019)
      • 5.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share by Type (2014-2019)
      • 5.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Price by Type (2014-2019)
      • 5.4 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Growth by Type (2014-2019)

      6 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis by Applications

      • 6.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption Market Share by Application (2014-2019)
      • 6.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Nanoparticles in Biotechnology and Pharmaceuticals Business

      • 7.1 Roche
        • 7.1.1 Roche Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 7.1.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction, Application and Specification
        • 7.1.3 Roche Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 GE Healthcare
        • 7.2.1 GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 7.2.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction, Application and Specification
        • 7.2.3 GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Merck
        • 7.3.1 Merck Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 7.3.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction, Application and Specification
        • 7.3.3 Merck Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Novartis
        • 7.4.1 Novartis Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 7.4.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction, Application and Specification
        • 7.4.3 Novartis Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 AMAG Pharmaceuticals
        • 7.5.1 AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 7.5.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction, Application and Specification
        • 7.5.3 AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Amgen
        • 7.6.1 Amgen Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 7.6.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction, Application and Specification
        • 7.6.3 Amgen Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Bausch & Lomb
        • 7.7.1 Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 7.7.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction, Application and Specification
        • 7.7.3 Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Biogen
        • 7.8.1 Biogen Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 7.8.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction, Application and Specification
        • 7.8.3 Biogen Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Celgene
        • 7.9.1 Celgene Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 7.9.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction, Application and Specification
        • 7.9.3 Celgene Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Gilead
        • 7.10.1 Gilead Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 7.10.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Introduction, Application and Specification
        • 7.10.3 Gilead Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Ipsen
      • 7.12 Leadiant Biosciences
      • 7.13 nanoComposix
      • 7.14 Pacira Pharmaceuticals
      • 7.15 Pfizer
      • 7.16 Shire

      8 Nanoparticles in Biotechnology and Pharmaceuticals Manufacturing Cost Analysis

      • 8.1 Nanoparticles in Biotechnology and Pharmaceuticals Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Nanoparticles in Biotechnology and Pharmaceuticals
      • 8.4 Nanoparticles in Biotechnology and Pharmaceuticals Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Nanoparticles in Biotechnology and Pharmaceuticals Distributors List
      • 9.3 Nanoparticles in Biotechnology and Pharmaceuticals Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast

      • 11.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue Forecast
        • 11.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Price and Trend Forecast (2019-2025)
      • 11.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue Forecast (2019-2025)
      • 11.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Consumption Forecast (2019-2025)
        • 11.3.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Consumption Forecast (2019-2025)
        • 11.3.3 China Nanoparticles in Biotechnology and Pharmaceuticals Consumption Forecast (2019-2025)
        • 11.3.4 Japan Nanoparticles in Biotechnology and Pharmaceuticals Consumption Forecast (2019-2025)
      • 11.4 Global Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules
        The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology.
        Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.

        The global Nanoparticles in Biotechnology and Pharmaceuticals market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Nanoparticles in Biotechnology and Pharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nanoparticles in Biotechnology and Pharmaceuticals market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Roche
        GE Healthcare
        Merck
        Novartis
        AMAG Pharmaceuticals
        Amgen
        Bausch & Lomb
        Biogen
        Celgene
        Gilead
        Ipsen
        Leadiant Biosciences
        nanoComposix
        Pacira Pharmaceuticals
        Pfizer
        Shire

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Fullerenes
        Liquid Crystals
        Liposomes
        Nanoshells
        Quantum dots
        Superparamagnetic nanoparticles

        Segment by Application
        Biotechnology
        Pharmaceutical

        Buy now